KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in KalVista Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −7 vs. Q3 2021
- Shares held
- 23.8M
- +405.6K (+1.7%) vs. Q3 2021
- Total value
- $314.6M
- −$93.6M (−22.9%) vs. Q3 2021
- New holders
- 16
- 32 more added
- Sold out
- 23
- 28 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −136,554−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,715−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −31,254−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,296−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −23,871−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,797−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,173−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −18,229−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,036−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,222−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,623−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,689−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| First Mercantile Trust Co | – | – | – | – | Not filed |